Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403,preparing for multiple ascending dose 4 mg cohort.
Oct 15, 2024
With Indonesian Andika Rama coming in second in the Individual Championship,and Team Indonesia coming in first place in the Country Championship
Oct 15, 2024
BEIJING,Oct. 15,2024--DBN Group,a leading high-tech agricultural enterprise,has opened its Phoenix International Innovation Park for global applications from high-quality agricultural biotech companie
Oct 15, 2024
Aidoc\'s AI technology enhances radiology services at IDX,significantly improving patient care and service and well-placed to support the upcoming National Lung Cancer Screening Program.
Oct 15, 2024
XI\'AN,China,Oct. 15,2024--The 10th Silk Road International Arts Festival began on the evening of October 12 in Xi\'an,Shaanxi,commemorating a decade of cultural exchange and artistic celebration. Mor
Oct 15, 2024
SHANGHAI,Sept. 23,2024-- At HUAWEI CONNECT 2024,Huawei successfully held the optical summit themed "Accelerate F5G-A,Amplify Intelligence". At the summit,Huawei launched new F5G Advanced (F5
Sep 24, 2024
BEIJING,Sept. 23,2024-- On September 19,the 2024 ChinaApsara Conference,a major annual event for the Chinese cloud computing industry,commenced in Hangzhou. Over three days,industry representatives,me
Sep 24, 2024
OXFORD,England,Sept. 23,2024-- FluoRok,an Oxford-based start-up,has raised £7.7m to scale-up,manufacture and commercialise novel fluorochemical reagents and battery electrolyte salts. The overs
Sep 24, 2024
SINGAPORE,Sept. 23,2024-- Advantech (TWSE: 2395),a global leader in industrial IoT and embedded computing solutions,has officially inaugurated its expanded regional office in Singapore. This strategic
Sep 24, 2024
BEIJING,Sept. 23,2024-- A report from China Daily: The opening ceremony of the seventh Silk Road (Dunhuang) International Cultural Expo in Dunhuang,Gansu province.
Sep 24, 2024
SINGAPORE,Sept. 23,2024-- To raise awareness of the importance of Will Planning,Summit Planners are running monthly Will Planning seminars to encourage the members of the public to take action to ens
Sep 24, 2024
SHANGHAI,Sept. 23,2024-- On September 14,2024,BioCity presented interim clinical results on the safety and efficacy of its first-in-class antibody-drug conjugate (ADC) BC3195 targeting CDH3 (P-Cadheri
Sep 24, 2024
Singapore Technology Information: Your Source for Tech, AI, Aerospace, Biotech News
© Singapore Technology Information Privacy Policy Contact us